Llusern Scientific is delighted to announce that two abstracts have been accepted for poster presentation at the British Society for Antimicrobial Chemotherapy (BSAC) UTI conference at the Royal College of Physicians in London on 14 June 2023.

The posters focus on the role of point of care diagnostics in improving the diagnosis of Urinary Tract Infections and challenge the reliance on culture testing as the standard methodology for diagnosis.

The abstracts are entitled:

“Performance of a novel molecular test designed for Point-of-Care UTI diagnosis”


“Rethinking UTI diagnosis: How gold is the ‘gold standard’ and how much does AST really matter?”

Emma Hayhurst will be attending ‘The Challenge of Urinary Tract Infections’ on behalf of Llusern.

The Lodestar DX analyser and testing system is registered with the European Patent Office (European Patent Application no: 22732302.9) and the US Patent and Trademark Office (no.18/558,490).